Insider · CIK 0001302445

Brinkley David L

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001302445

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−18K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.2K sh	—	—	0
2019-07-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2019-06-06	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2019-06-06	ARATANA THERAPEUTICS, INC.A Award	Director	AAward	+4,500 sh	—	—	18,000
2018-07-27	ARATANA THERAPEUTICS, INC.A Award	Director	AAward	+4,500 sh	—	—	13,500
2018-07-27	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2017-06-21	ARATANA THERAPEUTICS, INC.A Award	Director	AAward	+4,500 sh	—	—	9,000
2017-06-21	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2016-06-24	ARATANA THERAPEUTICS, INC.A Award	Director	AAward	+4,500 sh	—	—	4,500
2016-06-24	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2015-06-18	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2014-03-27	ARATANA THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+13.2K sh	—	—	13,237
2013-05-29	INVAInnoviva, Inc.S Sale	Head of Business Dev.	SSale	−3,808 sh	$35.01	−$133K	48,749
2013-05-20	INVAInnoviva, Inc.F Tax Payment	Head of Business Dev.	FTax Payment	−2,443 sh	$37.01	−$90.4K	52,557
2013-05-13	INVAInnoviva, Inc.M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	+16.1K sh	$34.00	+$548K	71,129
2013-05-13	INVAInnoviva, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	−16.1K sh	—	—	0
2013-05-13	INVAInnoviva, Inc.S Sale	Head of Business Dev.	SSale	−16.1K sh	$40.33	−$650K	55,000
2013-05-03	INVAInnoviva, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	−16.1K sh	—	—	0
2013-05-03	INVAInnoviva, Inc.M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	+16.1K sh	$29.65	+$478K	71,129
2013-05-03	INVAInnoviva, Inc.S Sale	Head of Business Dev.	SSale	−16.1K sh	$34.77	−$561K	55,000
2013-04-30	INVAInnoviva, Inc.M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	+8,333 sh	$6.15	+$51.2K	72,104
2013-04-30	INVAInnoviva, Inc.S Sale	Head of Business Dev.	SSale	−17K sh	$33.76	−$574K	55,100
2013-04-30	INVAInnoviva, Inc.S Sale	Head of Business Dev.	SSale	−100 sh	$34.35	−$3,435	55,000
2013-04-30	INVAInnoviva, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	−8,333 sh	—	—	0
2013-02-20	INVAInnoviva, Inc.F Tax Payment	Head of Business Dev.	FTax Payment	−3,416 sh	$22.10	−$75.5K	63,771
2013-02-07	INVAInnoviva, Inc.A Award	Head of Business Dev.	AAward	+5,000 sh	—	—	67,187
2012-11-20	INVAInnoviva, Inc.F Tax Payment	Head of Business Dev.	FTax Payment	−3,054 sh	$21.08	−$64.4K	62,187
2012-10-15	INVAInnoviva, Inc.A Award	Head of Business Dev.	AAward	+5,000 sh	—	—	65,241
2012-08-24	INVAInnoviva, Inc.S Sale	Head of Business Dev.	SSale	−3,483 sh	$27.50	−$95.8K	60,241
2012-08-20	INVAInnoviva, Inc.F Tax Payment	Head of Business Dev.	FTax Payment	−3,057 sh	$27.01	−$82.6K	63,724
2012-08-03	INVAInnoviva, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	−91.7K sh	—	—	8,333
2012-08-03	INVAInnoviva, Inc.S Sale	Head of Business Dev.	SSale	−124K sh	$27.92	−$3.46M	66,781
2012-08-03	INVAInnoviva, Inc.M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	+15.1K sh	$18.37	+$277K	190,698
2012-08-03	INVAInnoviva, Inc. · Common Stock (Right to Buy)M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	−15.1K sh	—	—	0
2012-08-03	INVAInnoviva, Inc.M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	+91.7K sh	$6.15	+$564K	175,608
2012-05-20	INVAInnoviva, Inc.F Tax Payment	Head of Business Dev.	FTax Payment	−2,402 sh	$20.33	−$48.8K	83,941
2012-02-20	INVAInnoviva, Inc.F Tax Payment	Head of Business Dev.	FTax Payment	−5,318 sh	$18.54	−$98.6K	86,343
2012-02-15	INVAInnoviva, Inc.A Award	Head of Business Dev.	AAward	+5,000 sh	—	—	91,661
2011-11-20	INVAInnoviva, Inc.F Tax Payment	Head of Business Dev.	FTax Payment	−1,887 sh	$22.34	−$42.2K	86,661
2011-08-20	INVAInnoviva, Inc.F Tax Payment	Head of Business Dev.	FTax Payment	−1,889 sh	$17.50	−$33.1K	88,548
2011-05-31	INVAInnoviva, Inc.S Sale	Head of Business Dev.	SSale	−51.5K sh	$25.65	−$1.32M	90,437
2011-05-31	INVAInnoviva, Inc.M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	+1,039 sh	$18.37	+$19.1K	141,937
2011-05-31	INVAInnoviva, Inc.M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	+44.4K sh	$9.69	+$430K	140,898
2011-05-31	INVAInnoviva, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	−1,039 sh	—	—	15,090
2011-05-31	INVAInnoviva, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Head of Business Dev.	MExercise/Conversion	−44.4K sh	—	—	0

Recent filings

Accepted (ET)
Jul 184
Brinkley David L0001209191-19-042717
SEC(opens sec.gov)
Jun 74
Brinkley David L0001209191-19-035630
SEC(opens sec.gov)
Jul 304
Brinkley David L0001209191-18-044446
SEC(opens sec.gov)
Jun 234
ARATANA THERAPEUTICS, INC.0001209191-17-041734
SEC(opens sec.gov)
Jun 284
ARATANA THERAPEUTICS, INC.0001209191-16-129937
SEC(opens sec.gov)
Jun 194
ARATANA THERAPEUTICS, INC.0001209191-15-055139
SEC(opens sec.gov)
Mar 284
ARATANA THERAPEUTICS, INC.0001181431-14-014317
SEC(opens sec.gov)
May 314
Brinkley David L0001179110-13-009448
SEC(opens sec.gov)
May 224
Brinkley David L0001179110-13-008887
SEC(opens sec.gov)
May 154
Brinkley David L0001179110-13-008498
SEC(opens sec.gov)

Companies

Address

THERAVANCE, INC. 901 GATEWAY BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080